Liver-specific enhancer II is the target for the p53-mediated inhibition of hepatitis B viral gene expression. - Wikidata - wikimedia - TriplyDB

Liver-specific enhancer II is the target for the p53-mediated inhibition of hepatitis B viral gene expression.

Liver-specific enhancer II is the target for the p53-mediated inhibition of hepatitis B viral gene expression.

http://www.wikidata.org/entity/Q47791939

about

The p53-microRNA-34a axis regulates cellular entry receptors for tumor-associated human herpes viruses.Seek protein which can interact with hepatitis B virus X protein from human liver cDNA library by yeast two-hybrid system.Virus associated malignancies: the role of viral hepatitis in hepatocellular carcinoma.Hepatitis B virus core promoter mutations G1613A and C1653T are significantly associated with hepatocellular carcinoma in genotype C HBV-infected patients Possible role of tocopherols in the modulation of host microRNA with potential antiviral activity in patients with hepatitis B virus-related persistent infection: a systematic review.Sodium selenite suppresses hepatitis B virus transcription and replication in human hepatoma cell lines.New potential instrument to fight hepatocellular cancer by restoring p53 p73beta inhibits transcriptional activities of enhancer I and X promoter in hepatitis B virus more efficiently than p73alpha.Association between Hepatitis B Virus X Gene Mutations and Clinical Status in Patients with Chronic Hepatitis B Infection Merlin neutralizes the inhibitory effect of Mdm2 on p53.Characterization of HBV integrants in 14 hepatocellular carcinomas: association of truncated X gene and hepatocellular carcinogenesis.

P2860

Q30412209-5E4D623E-B21F-493E-A751-F3495E4925A8 Q30724254-3E2BC160-547C-495C-AFEE-A578195C1D81 Q33723810-3DAF044D-2A99-4E6F-9155-75E15D9B828F Q34052514-B4B72363-A161-48A4-80F7-B3EF65099A0C Q35343911-A5EEF178-5F00-4730-926E-CDC4276482AA Q38838683-E18381FC-A17A-47CB-8A63-C0969A07FC88 Q39018547-B758F2B0-B8A4-4DE9-B2E7-F95E2D885ED5 Q40688905-113EC433-14DF-4747-B39F-F2823428F893 Q41913122-2F7B1027-32F1-456D-BB35-BA8B2C61AFD8 Q42833103-B9626A17-9852-4ADB-B6CC-97D631AFDE59 Q53371976-B90BCD6F-0C68-4FC9-8A8C-9FCF8B2BD5C7

P2860

Liver-specific enhancer II is the target for the p53-mediated inhibition of hepatitis B viral gene expression.

http://www.wikidata.org/entity/Q47791939

description

1998 nî lūn-bûn

@nan

1998年の論文

@ja

1998年学术文章

@wuu

1998年学术文章

@zh

1998年学术文章

@zh-cn

1998年学术文章

@zh-hans

1998年学术文章

@zh-my

1998年学术文章

@zh-sg

1998年學術文章

@yue

1998年學術文章

@zh-hant

name

Liver-specific enhancer II is ...... titis B viral gene expression.

@en

Liver-specific enhancer II is ...... titis B viral gene expression.

@nl

type

label

Liver-specific enhancer II is ...... titis B viral gene expression.

@en

Liver-specific enhancer II is ...... titis B viral gene expression.

@nl

prefLabel

Liver-specific enhancer II is ...... titis B viral gene expression.

@en

Liver-specific enhancer II is ...... titis B viral gene expression.

@nl

P1433

Q47791939-C29C8C88-EFC5-4CAC-9A2B-9A050FA66580

P1476

Q47791939-8426E987-AA89-41FC-A8FD-2C09E928BC56

P2093

Q47791939-51C85A1A-E10A-40C2-8A1F-B5504422DC15

Q47791939-DC2F47C4-7704-4D21-BC0A-D15357CE00BB

Q47791939-EB9CD67C-EF76-496D-8F20-D39FD5EE0531

P2860

Q47791939-01E726B6-AE2F-438A-A718-AEBBC5EB85BF

Q47791939-025A5616-935F-413D-B671-F98BB376B9D0

Q47791939-0F2DEAEE-C96C-4EEA-B56C-86B907C0D495

Q47791939-13C1EA22-05DA-4F92-9289-090874CB9E47

Q47791939-26775928-3B88-46E1-95C5-D01F5DCAFED9

Q47791939-2A5B1269-D352-41BF-886F-FE9E893C5222

Q47791939-406E3394-DF94-41D6-B5AA-4CF80528A28C

Q47791939-43A4FE94-B75F-40D7-A3B5-1BE17510C0E2

Q47791939-4FD515D8-A11B-4AFB-B589-894FBE9C6ABD

Q47791939-5192CCF6-412D-4FE1-8413-5E27B5BDCA1C

P304

Q47791939-25167038-E54E-4487-99CF-0C8D2B3DF0F0

P31

Q47791939-0A694576-5382-4708-9DFB-ECF55BA47FF6

P356

Q47791939-C4496147-147D-4212-8099-A5D378BD1850

P407

Q47791939-2FD37E21-8F4A-4DED-A6A9-FA9A1065CB26

P433

Q47791939-5446D131-FFE2-4C16-8B00-94E5F1397176

P478

Q47791939-B9F10D75-BF4A-4838-A14E-22B8F11E60BD

P577

Q47791939-E76A2AD7-4F3D-4074-AF97-CBC69D107D30

P5875

Q47791939-26805C0A-A92B-4C4D-AD2C-996D041D5B37

P698

Q47791939-30C18409-1D16-49F3-97E4-29EF40FA8A02

P356

JBC.273.31.19786

P1433

Journal of Biological Chemistry

P1476

Liver-specific enhancer II is ...... titis B viral gene expression.

@en

P2093

Kim HT

http://www.w3.org/2001/XMLSchema#string

Lee H

http://www.w3.org/2001/XMLSchema#string

Yun Y

http://www.w3.org/2001/XMLSchema#string

P2860

Wild-type p53 binds to the TATA-binding protein and represses transcription

Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor alpha

Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei

Definition of a consensus binding site for p53

Identification of p53 as a sequence-specific DNA-binding protein

p53: puzzle and paradigm

Transcriptional activation by Sp1 as directed through TATA or initiator: specific requirement for mammalian transcription factor IID

Multiple liver-specific factors bind to the hepatitis B virus core/pregenomic promoter: trans-activation and repression by CCAAT/enhancer binding protein.

Hepatitis B virus HBx protein deregulates cell cycle checkpoint controls

p53 binds and represses the HBV enhancer: an adjacent enhancer element can reverse the transcription effect of p53

P304

19786-19791

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.273.31.19786

http://www.w3.org/2001/XMLSchema#string

P407

P433

31

http://www.w3.org/2001/XMLSchema#string

P478

273

http://www.w3.org/2001/XMLSchema#string

P577

1998-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13608469

http://www.w3.org/2001/XMLSchema#string

P698

9677410

http://www.w3.org/2001/XMLSchema#string